Anti-Mi2 Inclusion body myositis Inflammation DM Skeletal muscle Amyotrophic lateral sclerosis Deep immune profiling Multidisciplinarity Polymyositis Auto‐antibodies Immune checkpoint inhibitors AAV humoral immunity Adeno-associated virus vector Myopathy Anti-agalsidase antibodies Myocarditis Auto-antibodies Anémie hémolytique IBM Male Dependovirus/genetics/immunology Outcome measures Biomarker Middle Aged CD8+ T-bet+ cells Humans Assisted communication devices Active IMNM Data integration Anti-IgE IgG Anti-interleukin-6 Lysosomal storage diseases Autoantibody Auto-immunité Muscle Antiphospholipid syndrome Inborn errors of metabolism Abnormal movement Cancer Inflammatory myopathy Immunotherapy Agalsidase Adult Biomarkers Autoimmune diseases Amyotrophy Gene therapy Anti-drug antibodies Anti-synthetase syndrome Arthritis Cytokines Female Interferon B-lymphocyte Anticorps spécifique des myosites Antisynthetase Analyses multidimensionnelles Animals AAV Aldostérone Antibodies Adeno-associated virus CD8+T cells Acid-alpha-glucosidase AAV vectors Sphingosine-1-phosphate Bioelectrical impedance analysis Mass cytometry Myositis Adverse drug reactions Machine learning Adeno-associated vector Aldosterone Adolescence Autoimmunity Antibody responses AAV vector Acute Kidney Injury/epidemiology/etiology Anti‐mitochondrial antibodies B cell homeostasis Interstitial lung disease Systems biology Anti-MDA5 autoantibodies Autoantibodies Adjudication Anticorps anti-agalsidase Biopsy COVID-19 Dermatomyositis Case reports Myositis and muscle disease AAV antibody Fabry disease Biomarqueurs Prognosis Idiopathic inflammatory myopathies Antisynthetase syndrome Aged Antisynthétase